Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra QIXLEEF will replace opioid

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Oct 24, 2021 8:36pm

145 Views

Post# 34043155

Tetra QIXLEEF will replace opioid

Phase 1 trials completed successfully. Phase 2 reborn trial started may are accelerated based on 1st few patients data. Further accelerated by Sites added on September. Obviously the trials are giving great results. Interim reports will present all the relevant data curves ets that shows superiority of QIXLEEF over opioid. It is done guys. I'm just waiting to see how Guy will play it. Interim reports are not even in FDA hand it is in Tetra hand. Add slowly wait for the nr any time Q4. Go slowly in loading. Added few more on Friday still not fully loaded yet but will be patient. GL long

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China